Industry News
Students win Australian finals of 2012 Imagine Cup with handheld digital stethoscope to detect pneumonia
A team of Victorian university students has invented a digital stethoscope that could help millions in the developing world by assisting in the early diagnosis of childhood pneumonia. The four students, known as ‘Team StethoCloud’, triumphed against four other teams to win the Australian finals of the 2012 Microsoft Imagine Cup challenge. [ + ]
AtCor launches improved blood pressure test
AtCor Medical (ASX:ACG) has launched SphygmoCor XCEL, the newest iteration of its non-invasive central aortic blood pressure monitoring device. [ + ]
Osprey Medical completes $20m IPO
Shares in Osprey Medical (ASX:OSP), a US medical device company commercialising a product which uses Australian IP, began trading on the ASX on Wednesday. [ + ]
Australian scientist using light to detect explosives
An Australian discovery has led to a portable new way to detect explosives using light-emitting molecules, offering an important tool to combat terrorism and remove land mines in war-torn countries. [ + ]
Australian researchers receive boost with IP reforms
Australian researchers now have the freedom to carry out research without the fear of being sued for patent infringement following the introduction of new laws, according to Parliamentary Secretary for Industry and Innovation Mark Dreyfus. [ + ]
Handheld plasma torch is like a lightsaber against bacteria
A battery-powered handheld plasma torch developed by Australian and Chinese scientists has been shown to wipe out some of the nastiest bacteria on skin surfaces. [ + ]
Set price fees for R&D Tax Incentive claims and advance findings
Three tax-specialist accounting firms are offering AusBiotech members free consultations and set prices for R&D Tax Incentive claims and advance findings. [ + ]
UniQuest and Axiom Molecular sign radiopharma strategic alliance
UniQuest, The University of Queensland’s (UQ) main commercialisation company, has announced a $4.3 million strategic alliance with Axiom Molecular in radiopharmaceutical research, development and commercialisation. [ + ]
Ventus Medical launches $40m IPO
Ventus Medical, a US-based company that develops products for sleep-disordered breathing, has launched a $40 million IPO on the ASX. [ + ]
ResMed posts record $65m profit as US market strengthens
ResMed (ASX:RMD) has revealed its March quarter profit grew 21% to $65 million, on the back of strong demand for its respiratory products in the Americas. [ + ]
Allied Healthcare invests $1m into Coridon on back of herpes vaccine
Allied Healthcare (ASX:AHZ) has paid $1m to increase its stake in Coridon to 44.4%, due to the company's progress towards trials of its herpes vaccine. [ + ]
Celebrating 100 years of Australian Antarctic science
Australian and international experts will come together in Canberra this week to explore the diverse Antarctic science endeavours that have emerged since Sir Douglas Mawson led the Australasian Antarctic Expedition in 1911-1914. [ + ]
Australian Red Cross Blood Service launches multimillion-dollar processing facility
The Australian Red Cross Blood Service is today opening the largest blood processing facility in the Southern Hemisphere, ensuring we continue to have one of the safest blood supply systems in the world. [ + ]
New crop could transform Australian bioeconomy
The CSIRO has developed a variety of safflower with high oleic oil content that could become a key crop in Australia and around the world. [ + ]
Swiss insurers to reimburse Clinuvel’s Scenesse
Two Swiss insurers have agreed to reimburse Scenesse, developed by Clinuvel Pharmaceuticals (ASX:CUV), as a treatment for erythropoietic protoporphyria. [ + ]
